ResearcherHarbin Institute of TechnologyActive in the last 2 years

Mengmeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-0386-6955. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in pancreatic cancer. Co-author DOI 10.1038/s41416-025-03149-4 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huanjie Yang · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Huan Nie · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Kai Li · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Qingzhu Yang · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.